Supplement reference
Schisandra
A source-linked reference on Schisandra, evidence, safety and product identity. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
Ingredient and preparation
Schisandra products generally use Schisandra chinensis fruit or extract, but the preparation can vary.
Sources: National Library of Medicine, PubMed
Evidence and limits
The cited 12-week trial tested a Schisandra-soybean extract mixture in 80 people with hyperglycaemia. It cannot establish liver-health, stress or endurance outcomes for Schisandra alone or a different extract.
Sources: National Library of Medicine, PubMed
Safety and a useful record
Botanical extracts can interact with medicines. Do not use a fruit-extract label to self-manage liver symptoms or abnormal laboratory results.
Sources: National Library of Medicine, PubMed, National Center for Complementary and Integrative Health
Record species, fruit or extract wording, marker information and all medicines.
Sources: National Center for Complementary and Integrative Health
Published sources
- Efficacy and Safety of Omija (Schisandra chinensis) Extract Mixture on the Improvement of Hyperglycemia: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
National Library of Medicine, PubMed. Published 2022; accessed 6 September 2026.
Supports: An 80-person, 12-week trial of a Schisandra-soybean extract mixture in people with hyperglycaemia, not Schisandra alone.
- Safe Use of Complementary Health Products and Practices
National Center for Complementary and Integrative Health. Current NCCIH reference; accessed 6 September 2026.
Supports: General safety, interaction and contamination context. It does not establish ingredient-specific benefit.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.